Clinical
Signs of Recovery Following Stem-Cell Trial in Stroke Patients
Five stroke patients have shown small signs of recovery following the injection of stem cells into their brain.
More Clinical Articles
Clinical
U.S Specialty Drug Spending to Rise 67% by 2015
US spending on specialty drugs – drugs aimed at chronic, complex diseases such as cancer, multiple sclerosis (MS) and rheumatoid arthritis (RA) – will increase by 67% by the end of 2015, according to new forecasts.
Clinical
NICE Medtech Innovation Briefings To Support Med Device Development
NICE have announced the publication a new set of briefings designed to increase uptake of innovative medical devices and technologies within the NHS, driven by concerns that patients are not receiving the benefits of new technologies quickly enough.
Clinical
New Head of Eli Lilly: AllTrials' Agenda is a "Very Strange Debate"
Dr Jean-Michel Cosséry, the new UK managing director and vice president for its Northern Europe hub of Lilly, said that the AllTrials campaign to increase clinical trial data transparency was for him “a strange debate”.
Clinical
AbbVie Lose Their Chief Scientific Officer – What’s Happening to R&D?
John Leonard, Chief Scientific Officer and Vice-President of AbbVie will leave the company in the coming months after twenty years of service, this is just the latest in a series of senior-level R&D departures in the industry, so is this indicative of wider issues within R&D?
Clinical
Bio Boy! Developing Markets to See Surge in Biosimilar Drug Growth
The global biosimilar drug market for 2013 will see a 20% growth on last year’s figures to a whopping $2.44 billion, and a new survey indicates that this trend will continue to flourish for the next decade.
Clinical
New 3D Technology Offers Hope for Patients with a Heart Rhythm Disorder
An innovative form of 3D technology could eliminate atrial fibrillation caused by the electronic signals in the heart, a major step forward in the treatment of this condition.
Clinical
GSK to make Trial Data Available Online
GlaxoSmithKline (GSK) has announced plans to set up a new online system that will enable researchers to access anonymous patient-level data from its clinical trials.
Clinical
Molecular-Targeted Treatment for Cancer Through Patient-Donated Data
A US comprehensive Cancer Centre has discovered that a biological data facility can accelerate recruitment, lower costs, minimise trial size and expedite the testing of medicines during drug development.
Access and Evidence
India Tightens Clinical Trial Monitoring
India’s Drug Controller General is to increase monitoring of clinical trials following health activists’ pushing for tougher regulations in the Supreme Court, as concerns continue to arise about the safety and integrity of trials across the country.